Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

Related Articles by Review for PubMed (Select 11792748)

1.

Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

Sherman ME, Schiffman M, Cox JT; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group.

J Natl Cancer Inst. 2002 Jan 16;94(2):102-7.

2.

Findings to date from the ASCUS-LSIL Triage Study (ALTS).

Schiffman M, Solomon D.

Arch Pathol Lab Med. 2003 Aug;127(8):946-9. Review.

PMID:
12873166
3.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
4.

Management of cervical cytologic abnormalities.

Apgar BS, Brotzman G.

Am Fam Physician. 2004 Nov 15;70(10):1905-16. Review.

6.
7.

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review.

PMID:
16950021
8.

Chapter 14: Role of triage testing in cervical cancer screening.

Solomon D.

J Natl Cancer Inst Monogr. 2003;(31):97-101. Review.

PMID:
12807952
9.

The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.

Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J.

Int J Cancer. 2013 Jan 1;132(1):101-8. doi: 10.1002/ijc.27636. Epub 2012 Jun 13. Review.

PMID:
22610699
10.

[Role of high-risk human papillomavirus testing in the screening and management of cervical cancer precursors].

Jin Y, Pan LY.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):691-6. Review. Chinese.

11.

HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.

Apgar BS, Brotzman G.

Am Fam Physician. 1999 May 15;59(10):2794-801. Review.

12.

Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.

Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M.

Cancer Cytopathol. 2013 Dec;121(12):675-87. doi: 10.1002/cncy.21325. Epub 2013 Jul 23. Review.

PMID:
23881840
13.

Is human papillomavirus testing of value in clinical practice?

Kaufman RH, Adam E.

Am J Obstet Gynecol. 1999 May;180(5):1049-53. Review.

PMID:
10329854
14.
16.

[Can human papillomavirus testing and vaccination prevent cervical cancer?].

Lie AK, Bjørge T, Helland A, Hagen B, Skjeldestad FE, Hagmar B, Thoresen S.

Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2947-51. Review. Norwegian.

PMID:
11715778
17.

HPV testing: where are we now?

Bovicelli A, Bristow RE, Montz FJ.

Anticancer Res. 2000 Nov-Dec;20(6C):4673-80. Review.

PMID:
11205199
18.
19.

HPV testing and vaccination in Europe.

Leeson SC, Alibegashvili T, Arbyn M, Bergeron C, Carriero C, Mergui JL, Nieminen P, Prendiville W, Redman CW, Rieck GC, Quaas J, Petry KU.

J Low Genit Tract Dis. 2014 Jan;18(1):61-9. doi: 10.1097/LGT.0b013e318286b8d3. Review.

PMID:
23774078
20.

Human papillomavirus reporting: minimizing patient and laboratory risk.

Austin RM.

Arch Pathol Lab Med. 2003 Aug;127(8):973-7. Review.

PMID:
12873169
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk